| Allison Eddy | Cysteamine Effects on Extracellular Matrix Accumulation in Chronic Kidney Disease | Cystinosis Research Foundation | $267,208 | 12/31/07 |
| Janet Eary | PET in Correlative Studies in Sarcoma | Fighting Children's Cancer Foundation | $2,000 | 12/28/07 |
| Janet Englund | Virologic Studies of Children with Colds | University of Washington | $12,691 | 12/26/07 |
| Jerry Zimmerman | 1st Tier Drugs±Theophylline in Pediatric Severe Asthma | NICHHD | $206,599 | 12/24/07 |
| Michael Portman | Role of FcGamma Receptor Polymorphisms in Determining IVIG Response in Kawasaki Disease | Thrasher Research Fund | $388,040 | 12/19/07 |
| Bonnie Ramsey | CSA: Vertex International DF Advisory Board | Vertex Pharmaceuticals, Inc. | $28,000 | 12/19/07 |
| Bonnie Ramsey | CSA: Subject Matter and Therapeutic Expertise Relative to CF Drug Development | Vertex Pharmaceuticals, Inc. | $25,000 | 12/19/07 |
| Bryan King | Fluoxetine in Autism: 14-week Study to Investigate Effect in Repetitive Behaviors in Autistic Spectrum Disorder | Neuropharma LTD | $25,080 | 12/12/07 |
| Carol Wallace | Childhood Arthritis and Rheumatology Research Alliance | Stanford University | $159,180 | 12/07/07 |
| Jeffrey Geyer | Informed Consent in Pediatric Phase I Cancer Trials | Cleveland Clinic Foundation | $48,329 | 12/03/07 |
| Carol Wallace | CARRA-Pfizer Drug Safety Surveillance Project | Pfizer, Inc. | $289,050 | 12/02/07 |